REVELATION BIOSCIENCES INC (REVB)

US76135L5075 - Common Stock

1.04  +0.22 (+26.83%)

After market: 0.99 -0.05 (-4.81%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

REVELATION BIOSCIENCES INC

NASDAQ:REVB (11/11/2024, 8:00:01 PM)

After market: 0.99 -0.05 (-4.81%)

1.04

+0.22 (+26.83%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-48.51%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap3.91M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

REVB Daily chart

Company Profile

Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. The company is headquartered in San Diego, California and currently employs 9 full-time employees. The company went IPO on 2020-10-08. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).

Company Info

REVELATION BIOSCIENCES INC

4660 Lajolla Village Drive, Suite 100

San Diego CALIFORNIA

P: 16508003717

Employees: 9

Website: https://www.revbiosciences.com/

REVB News

ChartMill News Image15 hours ago - ChartmillThese stocks have an unusual volume in today's session

Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.

ChartMill News Image20 hours ago - ChartmillMonday's pre-market session: top gainers and losers

What's going on in Monday's pre-market session

ChartMill News Image3 days ago - ChartmillFriday's after hours session: top gainers and losers

Curious about the stocks that are showing activity after the closing bell on Friday?

News Image4 days ago - Revelation Biosciences, Inc.Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
News Image2 months ago - Revelation Biosciences, Inc.Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
News Image3 months ago - Revelation Biosciences Inc.Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

REVB Twits

Here you can normally see the latest stock twits on REVB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example